If Neuren were to potentially hit each benchmark regarding successful trial results and can commercialise its product for all brain diseases excluding excluding Autism. What could the company potentially be worth or sold for?
Cheers,
- Forums
- ASX - By Stock
- NEU
- The Case for Yes
The Case for Yes, page-28
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B |
Open | High | Low | Value | Volume |
$15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 696 | $15.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.67 | 6942 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 696 | 15.590 |
2 | 5987 | 15.580 |
2 | 5540 | 15.570 |
2 | 1966 | 15.560 |
1 | 10578 | 15.550 |
Price($) | Vol. | No. |
---|---|---|
15.670 | 6942 | 8 |
15.690 | 1782 | 1 |
15.710 | 2 | 1 |
15.720 | 1782 | 1 |
15.740 | 1782 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online